Ensysce Biosciences (ENSC) AGM 2025 summary

Opening remarks and agenda

• The meeting was called to order virtually, with all board members introduced and the agenda outlined, including voting on five key proposals.

• The virtual format was continued to ensure safety and accessibility for all stockholders.

• Stockholders were informed about voting procedures and the opportunity to submit questions electronically.

Board and executive committee updates

• Board composition was reviewed, with specific committee roles highlighted for each director.

• Andrew Benton was acknowledged for his service as he is not standing for reelection.

Shareholder proposals

• Proposal 1: Approval for full issuance of shares and exercise of warrants to comply with NASDAQ rules.

• Proposal 2: Amendment to increase shares under the 2021 Omnibus Incentive Plan from 121,457 to 721,457.

• Proposal 3: Election of William Chang and Lee Rauch as Class I Directors until 2028.

• Proposal 4: Ratification of Baker Tilly US, LLP as independent auditor for 2025.

• Proposal 5: Adjournment proposal, only to be considered if needed.